Thrombospondin Levels in Patients with Malignancy

Summary

Thrombospondin (TSP), a large glycoprotein present in platelets, and various normal and tumor tissues, has recently been shown to promote cell adhesion and platelet aggregation. Most importantly because TSP has been shown to promote metastasis of melanoma tumor cells to the lung in a murine model (1) and since thromboembolic events commonly occur in patients afflicted with metastatic tumors, we explored the role of TSP in human cancer by measuring TSP blood levels in patients with various malignant neoplasms. Blood TSP levels were measured by indirect enzyme-linked immunoadsorbent assay (ELISA) from 20 control subjects, 22 patients with gastrointestinal (GI) cancer, 18 patients with breast cancer, and 17 patients with lung cancer. Control subjects consisted both of healthy subjects and acutely ill patients with no malignancies. TSP levels of both healthy and acutely ill controls were found to range between 245-440 μg/ml with a mean of 365 μg/ml. In contrast, elevated levels of TSP greater than the mean value of 400 μg/ml for controls ranging between 590-3,650 μg/ml were found in 20/22 (91%) patients with GI malignancies, 13/18 (72%) patients with breast cancer, and 15/17 (88%) with lung cancer. Mean TSP levels of GI, breast, and lung cancer patients were 3, 2, and 3 fold greater than controls, respectively. Increased blood TSP levels in patients were not due to increased levels of platelets since both control and patient groups had platelet counts within the normal range. These results suggest that TSP may play a role in tumor cell metastasis in man and could serve as a blood marker for metastasis.

• References

• 1 Tuszynski GP, Gasic TB, Rothman VL, Knudsen KA, Gasic GJ. Thrombospondin potentiates tumor cell metastasis. Cancer Res 1987; 47: 4130-4133
• 2 Tuszynski GP, Srivastava S, Switalska HI, Holt JC, Cierniewski CS. The interaction of human thrombospondin with fibrinogen. J Biol Chem 1985; 260: 12240-12245
• 3 McPherson J, Sage H, Bornstein P. Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture: apparent identity with platelet thrombospondin. J Biol Chem 1981; 256: 11330-11336
• 4 Mosher DF, Doyle MF, Jaffe EA. Synthesis and secretion of thrombospondin by cultured endothelial cells. J Cell Biol 1982; 93: 343-348
• 5 Raugi GJ, Mumby SM, Abbott-Brown D, Bornstein P. Thrombospondin synthesis and secretion by cells in culture. J Cell Biol 1982; 95: 351-354
• 6 Jaffe EA, Ruggiero JT, Leung LLK, Doyle MJ, McKeown-Longo PJ, Mosher DF. Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci USA 1986; 80: 998-1002
• 7 Sage H, Farin FM, Striker GE, Fisher AB. Granular pneumocytes in primary culture secrete several major components of the extracellular matrix. Biochemistry 1983; 22: 2148-2155
• 8 Jaffe EA, Ruggiero JT, Falcone DJ. Monocytes and macrophages synthesize and secrete thrombospondin. Blood 1985; 65: 79-84
• 9 Mosher DF. Physiology of thrombospondin. Annu Rev Med 1990; 41: 85-97
• 10 Riser BL, Varani J, O’Rourke K, Dixit VM. Thrombospondin binding by human squamous carcinoma and melanoma cells. Exp Cell Res 1988; 174: 319-329
• 11 Varani J, Riser BL, Hughes LA, Carey TE, Fligiel SEG, Dixit VM. Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells. Clin Exp Met 1989; 7: 265-276
• 12 Wight TN, Raugi GJ, Mumby SM, Bornstein P. Light microscopic immunolocalization of thrombospondin in human tissues. J Hist Cytochem 1985; 33: 295-302
• 13 Roberts DD, Sherwood JA, Ginsburg V. Platelet thrombospondin mediates attachment and spreading of human melanoma cells. J Cell Biol 1987; 104: 131-139
• 14 Tuszynski GP, Rothman V, Murphy A, Siegler K, Smith L, Smith S, Karczewski J, Knudsen K. Thrombospondin promotes cell-substratum adhesion. Science 1987; 236: 1570-1573
• 15 Taraboletti G, Roberts D, Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 1990; 111: 765-772
• 16 Tuszynski GP, Kowalska MA, Karczewski J, Eichen J, Rothman VL, Capuzzi DM. Thrombospondin and VLDL promote platelet adhesion-evidence for a common platelet adhesion receptor. Thromb Haemostas 1989; 62: 418
• 17 Tuszynski GP, Rothman VL, Murphy A, Siegler K, Knudsen KA. Thrombospondin promotes platelet aggregation. Blood 1988; 72: 109-115
• 18 Asch AD, Barnwell A, Silverstein RL, Nachman RL. Isolation of thrombospondin membrane receptor. J Clin Invest 1987; 79: 1054-1061
• 19 Taraboletti G, Roberts D, Liotta LA. Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different domains. J Cell Biol 1987; 105: 2409-2415
• 20 Pratt DA, Miller WR, Dawes J. Thrombospondin in malignant and non-malignant breast tissue. Eur J Cancer Clin Oncol 1989; 25: 343-350
• 21 Tuszynski GP, Switalska HI, Knudsen K. Modern methods in pharmacology. In: Methods of Studying Platelet-Secreted Proteins and the Platelet Cytoskeleton, Vol 4. Alan R Liss Inc; New York: 1987. pp 267-286
• 22 Gasic G, Gasic T, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 1968; 61: 46-52
• 23 Karpatkin S, Pearlstein E. Role of platelets in tumor cell metastasis. Ann Intern Med 1981; 95: 636-641
• 24 Bhatti R, Gadarowski J, Ray P. Correlation between function and metastasis of prostatic cancer. Clin Expl Met 1990; 8 (Suppl) (01) 73
• 25 Trousseau A. Phlegmasia albadolens. Clinique medicale de l’Hotel-Dieu de Paris. The New Sydenham Society; London: 1865. 3 94
• 26 Edwards RL, Rickies FR. Hemostatic alterations in cancer patients. In: Hemostatic Mechanisms and Metastasis. Honn JV, Sloane BF. (eds) Martinus Nijhoff; Boston, IL: 1984. p 343
• 27 Yamamura T, Matsumoto H, Maruyama Y. et al Clinical studies on platelet aggregation in patients with carcinoma of gastrointestinal tract. Thromb Haemostas 1981; 46: 31-35
• 28 Myers TJ, Rickies FR, Barb C. et al Fibrinopeptide A in acute leukemia: relationship of activation of blood coagulation to disease activity. Blood 1981; 57: 518-522
• 29 Bomstein P, O’Rourke K, Wikstrom K. et al A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. J Biol Chem 1991; 266: 12821-12824
• 30 Dawes J, Clemetson KJ, Gogstad GO. et al A radioimmunoassay for thrombospondin used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers. Thromb Res 1983; 29: 569-582
• 31 Murphy-Ullrich JE, Hook M. Thrombospondin modulates focal adhesions in endothelial cells. J Cell Biol 1989; 109: 1309-1319
• 32 Canfield AE, Boot-Handford RP, Schor AN. Thrombospondin gene expression by endothelial cells in culture is modulated by cell proliferation, cell shape and the substratum. Biochem J 1990; 268: 225-230
• 33 Nathan FE, Besa E, Swithalska HI, Joseph R, Tuszynski GP. Thrombospondin levels in patients with myelodysplastic and myeloproliferative disorders. Blood 1991; 78 (Supplement) (01) 35a